Zydus Lifesciences hits the sweet spot after approval for generic diabetes drug

Zydus Lifesciences has achieved a significant milestone by obtaining tentative approval from the US FDA for Dapagliflozin Tablets. Designed for individuals managing type 2 diabetes, these tablets will be produced in Ahmedabad. Notably, Dapagliflozin has previously witnessed impressive annual sales within the US market, indicating strong demand.